Literature DB >> 3654700

Surgical margins for soft-tissue sarcoma.

A Rydholm1, B Rööser.   

Abstract

A retrospective analysis was done of the rates of local recurrence in eighty-one patients in whom soft-tissue sarcomas in the extremities and the trunk were treated by surgery only. The minimum length of follow-up was six years or until death. The surgical margin was wide in all patients according to the definition of the surgical staging system of Enneking et al., but we defined three types of wide margin. None of them included a whole anatomical compartment, so that the radical resection, as defined by the surgical staging system, was excluded from the study. The crude rates of local recurrence in the three subgroups that were studied differed significantly. There was no correlation between the rate of local recurrence and the histological grade of malignancy. Our findings suggest that the subclassification of the wide margin that we have applied to the surgical staging system of Enneking et al. is of value. The low rates of recurrence (less than 10 per cent) for subcutaneous lesions, and intramuscular lesions that were treated by primary myectomy, were comparable with those of radical resections and usually were followed by minor loss of function. The higher rate of recurrence (30 per cent) for the third subgroup, which included deep tumors that were not treated by myectomy, was comparable with the rates found in other studies.

Entities:  

Mesh:

Year:  1987        PMID: 3654700

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  11 in total

1.  Feasibility study of clinical target volume definition for soft-tissue sarcoma using muscle fiber orientations derived from diffusion tensor imaging.

Authors:  Nadya Shusharina; Xiaofeng Liu; Jaume Coll-Font; Anna Foster; Georges El Fakhri; Jonghye Woo; Thomas Bortfeld; Christopher Nguyen
Journal:  Phys Med Biol       Date:  2022-07-22       Impact factor: 4.174

2.  Preoperative diagnosis of soft tissue tumours.

Authors:  A Rydholm; T Alvegård; N O Berg; Z Dawiskiba; N Egund; I Idvall; H Pettersson; B Rööser; H Willén; M Akerman
Journal:  Int Orthop       Date:  1988       Impact factor: 3.075

3.  A review of controversies in the management of soft tissue sarcomas.

Authors:  S V S Deo; N M L Manjunath; N K Shukla
Journal:  Indian J Surg       Date:  2012-06-20       Impact factor: 0.656

4.  Synovial sarcoma. A clinicopathological study of 31 cases.

Authors:  S Santavirta
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

5.  Reliability of Margin Assessment after Surgery for Extremity Soft Tissue Sarcoma: The SSG Experience.

Authors:  Clement S Trovik; Sigmund Skjeldal; Henrik Bauer; Anders Rydholm; Nina Jebsen
Journal:  Sarcoma       Date:  2012-06-18

6.  High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy.

Authors:  Benedikt Leidinger; Thomas Heyse; Andreas Schuck; Horst Buerger; Philipp Mommsen; Thomas Bruening; Susanne Fuchs; Georg Gosheger
Journal:  BMC Cancer       Date:  2006-06-18       Impact factor: 4.430

Review 7.  Management of myxoid liposarcoma of the extremity.

Authors:  Yehia Tfayli; Ahmad Baydoun; Ahmad Salaheddine Naja; Said Saghieh
Journal:  Oncol Lett       Date:  2021-06-09       Impact factor: 2.967

8.  Factors Influencing Prognosis After Initial Inadequate Excision (IIE) for Soft Tissue Sarcoma.

Authors:  Albert N Van Geel; Alexander M M Eggermont; Patrick E J Hanssens; Paul I M Schmitz
Journal:  Sarcoma       Date:  2003

9.  Primitive sarcoma of the breast: new insight on the proper surgical management.

Authors:  Vittorio Pasta; Massimo Monti; Michela Cialini; Massimo Vergine; Paolo Urciuoli; Annunziata Iacovelli; Silvio Rea; Valerio D'Orazi
Journal:  J Exp Clin Cancer Res       Date:  2015-07-30

Review 10.  Rehabilitation to Improve the Function and Quality of Life of Soft Tissue and Bony Sarcoma Patients.

Authors:  Cody C Andrews; Geoffrey Siegel; Sean Smith
Journal:  Patient Relat Outcome Meas       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.